Purchase Order 75D30123P16486

Award Date 5/30/23
Potential Completion Date 6/12/27
Potential Value $110K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to 10X Genomics, Inc., a life sciences technology company, by the Centers for Disease Control and Prevention (CDC). The $75,072 firm fixed-price contract is for the provision of goods and services related to 10X Genomics' genomic analysis platforms, reagents, instruments, and bioinformatics software. These products and services support single-cell and spatial analysis applications, enabling high-throughput interrogation of biological systems at the single-cell...
The federal contract award with ID 75D30122P13807 was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility, a civilian agency, to 10X Genomics, Inc., a for-profit manufacturer of life sciences technology products and services. The $95,000.00 firm fixed price purchase order is for the delivery of the company's "CHROMIUM X" products and services, which include specialized kits, instruments, and associated services for single-cell and spatial analysis...
This federal contract award was made by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to 10X Genomics, Inc., doing business as 10X Genomics, a for-profit manufacturer of life sciences products and services. The $132,309.50 firm fixed price purchase order is for the provision of 10X Genomics' Chromium Single Cell product, which supports single-cell and spatial analysis applications. 10X Genomics has previously received awards from the National...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to 10X Genomics, Inc., doing business as 10X Genomics, for $102,601.16. 10X Genomics is a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The contract is for the delivery of laboratory equipment, with no set-aside used. 10X Genomics has previously provided specialized kits,...
This is a federal contract awarded by the Department of Health and Human Services' Centers for Disease Control and Prevention to 10X Genomics, Inc. for the provision of lab supplies valued at $162,392.88. The contract is a firm fixed price purchase order with a completion date of October 18, 2022. 10X Genomics, Inc. is a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The contract does not have a set-aside designation....
The Department of Health and Human Services' Centers for Disease Control and Prevention awarded a firm fixed price contract to 10X Genomics, Inc. for "CHROMIUM SINGLE CELL" products and services. The $134,995.00 contract does not have a set-aside designation. 10X Genomics, a life sciences technology company, provides genomic analysis platforms, reagents, instruments, and bioinformatics software to enable high-throughput interrogation of biological systems at single cell resolution....
This is a federal contract award from the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to 10X Genomics, Inc., a for-profit life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The contract, with a ceiling value of $75,114.00, is for the delivery of laboratory instruments. The contract type is a firm fixed price purchase order with an ultimate completion date of August 1, 2015. The contract...
This contract awards 10X Genomics, Inc., a purchase order for the company's Chromium Connect System for single cell workflow, which was a sole source procurement by the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services. The $249,950.00 firm fixed price contract provides laboratory equipment, with no set-aside used. 10X Genomics is a for-profit life sciences technology company that supplies a range of genomic analysis platforms, reagents,...
10X Genomics, Inc., doing business as 10X Genomics, has been awarded a firm fixed price purchase order valued at $249,649.15 by the Centers for Disease Control and Prevention (CDC) to provide single-cell RNA-seq library preparation services. The purpose of this contract is to support CDC's efforts to study the host immune response induced by influenza vaccines through transcriptomic analysis at the single-cell level. Performance will take place in Atlanta, Georgia over a two week period...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the prime contractor 10X Genomics, Inc., doing business as 10X Genomics. The contract, valued at $108,375.74, is for the provision of 10X Genomics' Chromium Next GEM Single Cell 5' HT Kit v2, Dual Index Kit TT Set A, and Library Construction Kit to support biomedical research efforts. This is a firm fixed price...

This federal contract award to 10X Genomics, Inc., a life sciences technology company, was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The $109,800 firm fixed price purchase order is for the company's specialized genomic analysis platforms, reagents, instruments, and bioinformatics software. These products, which include Chromium Next GEM Single Cell Kits, Visium Spatial Gene Expression systems, and Xenium Analyzers, support advanced biomedical research across various scientific domains such as infectious diseases, cancer, neurological disorders, and age-related conditions. While most of 10X Genomics' federal contracts are not set aside, the company has been awarded several small business set-aside contracts, particularly with the National Institute of Allergy and Infectious Diseases. The contract is part of a larger indefinite delivery contract (IDC) with the National Institute on Aging, valued at up to $7,000,000 and running through July 2029, focused on providing optimization slides, reagent kits, and reagent delivery methods to support research into neurological diseases and disorders.

Generated 6/13/25, 9:51 AM